ArticleScientific reports2025
Salvia sclarea L. mediated green synthesis of gold nanoparticles (AuNPs) and evaluation of their antibacterial, anticandidal, and scolicidal properties.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Plant-Mediated Synthesis of Silver Nanoparticles UsingNanomaterials (Basel, Switzerland) · 2026Article
- Green Synthesis of Gold Nanoparticles with Good Photothermal Properties and Antibacterial Activity from Black Corncob Extract.Nanomaterials (Basel, Switzerland) · 2026Article
- Curcuma longa debranched starch assisted synthesis of cerium oxide nanoparticles and its antioxidant, anticancer, antimicrobial, and anti-biofilm activities.Scientific reports · 2026Article
- Recent advances in the detection and treatment of hydatid cysts by nanomaterial-based carriers.Iranian journal of basic medical sciences · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Gold nanoparticles (AuNPs) were biosynthesized using the aqueous extract of the aerial parts of Salvia sclarea L., and an environment-friendly and cost-effective method. These nanoparticles were then evaluated for antibacterial (4 standard bacterial strains), anti-candida (40 clinical isolates), and scolicidal effects. The UV-visible spectrophotometry revealed a maximum absorption peak at 548 nm for AuNPs. Field emission scanning electron microscopy (FE-SEM) showed that most particles had sizes in the 70–80 nm range. Also, energy-dispersive X-ray spectroscopy (EDX) and X-ray diffraction (XRD) were performed, revealing a crystal size of 11.2 nm, which was consistent with transmission electron microscopy (TEM), showing polygonal and spherical crystals between 20 and 50 nm. Dynamic light scattering (DLS) retrieved a mean diameter of 130.6 nm for these NPs. The reducing and stabilizing effects of the plant extract on AuNPs were confirmed by Fourier Transform Infrared Spectroscopy (FTIR). The AuNPs exhibited greater antimicrobial activity against Gram-positive bacteria, including Staphylococcus aureus and Bacillus cereus, than Gram-negative strains, such as Escherichia coli and Pseudomonas aeruginosa. Furthermore, these NPs showed noticeable activity against some Candida strains, such as Candida krusei and C. glabrata, but not against C. parapsilosis and C. albicans. The highest lethality (100%) of AuNPs against liver hydatid cyst protoscolices was obtained at the concentration of 320 µg/mL after 15 min treatment. Our results showed that the aqueous extract of S. sclarea L. could be a low-cost source for the biosynthesis of multifunctional AuNPs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.